Hao Liang

机构：Nanjing University of Chinese Medicine, Chinese University of Hong Kong, Shenzhen · ORCID：0000-0003-4382-3704

发表论文 38 篇 · 总被引 1107 次 · h-index 15

代表论文

• Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro (2021 · Journal of Enzyme Inhibition and Medicinal Chemistry · 被引 316)
• Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds (2020 · European Journal of Medicinal Chemistry · 被引 66)
• Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease (2021 · Signal Transduction and Targeted Therapy · 被引 57)
• Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro (2020 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 44)
• Predicting the local COVID-19 outbreak around the world with meteorological conditions: a model-based qualitative study (2020 · BMJ Open · 被引 31)
• Novel mutations in the PLCZ1 gene associated with human low or failed fertilization (2020 · Molecular Genetics & Genomic Medicine · 被引 22)